Advertisement

Executive Moves

Advertisement

   SAN DIEGO--(BUSINESS WIRE)--May 29, 2018-- Heron Therapeutics, Inc. (NASDAQ: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, announced that Barry D.…

Advertisement